Danaher

Danaher

Life Sciences Tools & Services
In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

$141.4B

Market Cap • 9/11/2026

1986

(40 years)

Founded

1978

(48 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

S&P500 Participant

Index Composite • 2026

Valuation

P/B

2,7

P/S

5,6

P/EBITDA

18,5

P/OCF

21,3

P/FCF

25,9

P/E

35,7

BVPS

74

EPS

5,6

Market Cap

Market Cap

141,4B

EV

163,6B

EV/Revenue

6,5

EV/EBITDA

21,4

EV/EBIT

31,9

Payout

Dividend Per Share

1,4

Dividend Yield

0,7%

Buyback Yield

2%

Total Yield

2,7%

Dividend Yield 5Y

0,6%

Payout

24,1%

Retained Earnings

48,2B

Profitability

Gross Margin

58,5%

EBITDA Margin

30,5%

EBIT Margin

20,4%

Net Margin

15,9%

D&A/EBITDA

0%

R&D/Revenue

6,4%

Capex/Revenue

4,7%

Capex/D&A

46,2%

Capex/OCF

17,6%

SBC/OCF

4,5%

% PPE

6,3%

% Goodwill

51,3%

ROE

7,6%

ROIC

5,3%

Growth

CAGR Revenue 5Y

-1,2%

CAGR Op. Income 5Y

-5,2%

CAGR Net Income 5Y

-6,3%

CAGR EPS 5Y

-5,3%

CAGR OCF 5Y

-3,9%

Leverage

N.D./EBITDA

2,9

Debt/Equity

0%

Current Ratio

1,7

Quick Ratio

1

Interest Coverage

1755,8%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium